Evidence map›Paper›PMID 36809777›Full record

ArticleThrombosis and haemostasis2023

Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study.

Behnood Bikdeli, Ying-Chih Lo, Candrika D Khairani, Antoine Bejjani, David Jimenez, Stefano Barco, Shiwani Mahajan, César Caraballo, Eric A Secemsky, Frederikus A Klok and 15 more

Abstract read
In one paragraph

Article in Thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Endovascular Therapies for Pulmonary Embolism: A Landscape of Uncertainties and Opportunities.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Behnood BikdeliDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.ORCID 0000-0003-1428-879X
Ying-Chih LoDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Candrika D KhairaniThrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Antoine BejjaniThrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
David JimenezRespiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.ORCID 0000-0002-4571-7721
Stefano BarcoDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-9961-0754
Shiwani MahajanYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
César CaraballoYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Eric A SecemskyRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States.
Frederikus A KlokDepartment of Medicine - Thrombosis and Hemostasis, Leiden University Medical Centre, Leiden, The Netherlands.
Andetta R HunsakerDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Ayaz AghayevDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Alfonso MurielClinical Biostatistics Unit. Hospital Universitario Ramón y Cajal. IRYCIS, CIBERESP: Universidad de Alcalá. Madrid, Spain.
Yun WangYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Mohamad A HussainDivision of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Abena Appah-SampongDepartment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Yuan LuYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Zhenqiu LinYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Sanjay AnejaDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, United States.
Rohan KheraYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Samuel Z GoldhaberDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Li ZhouDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Manuel MonrealCátedra de Enfermedad Tromboembólica, Universidad Católica de Murcia, Murcia, Spain.
Harlan M KrumholzYNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
Gregory PiazzaDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Funding

Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
American Heart Association-American Stroke Association 938814NHLBI NIH HHS K23 HL150290
6 · The paper itself

Abstract

backgroundContemporary pulmonary embolism (PE) research, in many cases, relies on data from electronic health records (EHRs) and administrative databases that use International Classification of Diseases (ICD) codes. Natural language processing (NLP) tools can be used for automated chart review and patient identification. However, there remains uncertainty with the validity of ICD-10 codes or NLP algorithms for patient identification.

methodsThe PE-EHR+ study has been designed to validate ICD-10 codes as Principal Discharge Diagnosis, or Secondary Discharge Diagnoses, as well as NLP tools set out in prior studies to identify patients with PE within EHRs. Manual chart review by two independent abstractors by predefined criteria will be the reference standard. Sensitivity, specificity, and positive and negative predictive values will be determined. We will assess the discriminatory function of code subgroups for intermediate- and high-risk PE. In addition, accuracy of NLP algorithms to identify PE from radiology reports will be assessed.

resultsA total of 1,734 patients from the Mass General Brigham health system have been identified. These include 578 with ICD-10 Principal Discharge Diagnosis codes for PE, 578 with codes in the secondary position, and 578 without PE codes during the index hospitalization. Patients within each group were selected randomly from the entire pool of patients at the Mass General Brigham health system. A smaller subset of patients will also be identified from the Yale-New Haven Health System. Data validation and analyses will be forthcoming.

conclusionsThe PE-EHR+ study will help validate efficient tools for identification of patients with PE in EHRs, improving the reliability of efficient observational studies or randomized trials of patients with PE using electronic databases.

Indexed as

Pulmonary EmbolismAlgorithmsElectronic Health RecordsHumansInternational Classification of DiseasesPredictive Value of TestsReproducibility of Results

Identifiers

PMID36809777
PMCPMC11200175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.